Hyperlipoproteinemia type 3: the forgotten phenotype.

about

A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms.Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

P2860

Q38781922-736B3DC4-B291-49F0-B563-BFE95A5D46BF Q58362346-D2BC8D7F-DFB8-461B-9EE3-A85D67DC2632

P2860

Hyperlipoproteinemia type 3: the forgotten phenotype.

Item

http://www.wikidata.org/entity/Q38235600

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Hyperlipoproteinemia type 3: the forgotten phenotype.

@en

type

Item

label

Hyperlipoproteinemia type 3: the forgotten phenotype.

@en

prefLabel

Hyperlipoproteinemia type 3: the forgotten phenotype.

@en

P1476

Hyperlipoproteinemia type 3: the forgotten phenotype.

@en

P2093

Eliot A Brinton

http://www.w3.org/2001/XMLSchema#string

M Nazeem Nanjee

http://www.w3.org/2001/XMLSchema#string

P2860

Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants

Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid

Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins

Apolipoprotein B secretory regulation by degradation

Apo E variants in patients with type III hyperlipoproteinemia

Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of l

Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia

Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics

Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia.

Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance

P2888

s11883-014-0440-2

P304

440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11883-014-0440-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul N Hopkins

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051953923

http://www.w3.org/2001/XMLSchema#string

P698

25079293

http://www.w3.org/2001/XMLSchema#string

Hyperlipoproteinemia type 3: the forgotten phenotype.

about

P2860

P2860

Hyperlipoproteinemia type 3: the forgotten phenotype.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698